Article
Improved method to measure urinary alkoxyacetic acids.
Institute of Occupational Safety and Health, Council of Labor Affairs, Taipei, Taiwan, Republic of China.
Occupational and Environmental Medicine (impact factor:
3.02).
08/1999;
56(7):460-7.
pp.460-7
Source: PubMed
- Citations (1)
-
Cited In (0)
-
Article: Synergistic interaction between interleukin-6 and interleukin-3 in support of stem cell proliferation in culture.
[show abstract] [hide abstract]
ABSTRACT: Interleukin-6 (Il-6), also known as B cell stimulatory factor 2/interferon beta 2, has been found to support colony formation by murine granulocyte-macrophage progenitors. We have reported that Il-6 also acts synergistically with interleukin-3 (Il-3) in the support of the proliferation of multipotential stem cells in the quiescent, Go phase of the cell cycle. Our serial observations (mapping studies) of the development of blast cell colonies from spleen cells harvested from mice 4 days after the injection of 150 mg/kg 5-fluorouracil revealed that the blast cell colonies appeared earlier in culture in the presence of Il-6 and Il-3 than with either factor alone. Because the combination of factors did not alter the rate of growth of the colony, this effect must result from an early exit from Go. In the human system using purified, My-10+ bone marrow progenitors in a culture system with delayed addition of growth factors, the combination of Il-6 and Il-3 yielded twice as many colonies as did Il-3 alone. The human blast cell colonies also appeared at earlier times when grown in the presence of Il-6 and Il-3 as compared to either factor alone. These results suggested that human Il-6 acts synergistically with Il-3 in the support of the proliferation of human and murine hemopoietic stem cells in Go and that part of the effect appears to be a shortening of the Go residence time of the hemopoietic stem cells.Blood cells 02/1988; 14(2-3):329-37.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
-20 degrees C
3 freeze-thaw cycles
average recoveries
biological monitoring
concentration range 0.3-200 micrograms/ml
concentrations
conventional analytical methods
current preparation
extraction time
gas chromatography/mass spectrometry
measure urinary alkoxyacetic acids
new GC/MS method
pooled coefficient
reliable method
replicate samples
Sakai's GC method
simplified non-derivatisation pretreatment
strong linear correlation
urine samples
urine samples MAA